Clinical Trial Update: Mild Hypofractionation With Proton Therapy or IMRT for Intermediate-Risk Prostate Cancer

View source ↗

Summary

Clinical trial update for mild hypofractionation using proton therapy or IMRT in intermediate-risk prostate cancer; the study is currently active but not recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Abramson Cancer Center at Penn Medicine | Conditions: Prostate Adenocarcinoma | Status: ACTIVE_NOT_RECRUITING